Lifecore Biomedical, Inc. · Brief

Next report

3 days

Nov 5 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

3 of 8≥ implied

Oct 4 '24±10.5%▲+14.35%×1.37

Jan 2 '25±19.2%▲+14.41%×0.75

Apr 3 '25±21.7%▼−22.32%×1.03

Aug 7 '25±10.4%▼−6.70%×0.64

Nov 6 '25±21.1%▲+3.47%×0.16

Q1 FY26±17.0%▼−33.26%×1.96

May 6 '26±13.3%▼−3.88%×0.29

Q2 FY26±35.1%▲+2.07%×0.06

quarterimplied−40%0+40%realized×

Q2 FY26±35.1%▲+2.07%×0.06

May '26±13.3%▼−3.88%×0.29

Q1 FY26±17.0%▼−33.26%×1.96

Nov '25±21.1%▲+3.47%×0.16

Aug '25±10.4%▼−6.70%×0.64

Apr '25±21.7%▼−22.32%×1.03

2 older reports

Jan '25±19.2%▲+14.41%×0.75

Oct '24±10.5%▲+14.35%×1.37

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2 of 3

100managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+2.86%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

44.00%revenue from the largest disclosed customer Alcon Research LLCSEC filings

5 of 8recent reports where the move came in under the options implied rangeEarnings history

AI captions · Sep 28 '26once per report · top 2 per case

LFCR report session

No linked exposure.

Oct 22impliedImplied move: ±23.3% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.